NFKB1 and osteosarcoma: Interestingly, the NF‐κB pathway is activated and is widely involved in osteosarcoma cell proliferation and differentiation by affecting bone morphogenetic protein (BMP) signaling or the glycogen synthase kinase‐3β (GSK‐3β) pathway (Tang et al., 2012).